12 Nov 2018 15:51
12 November 2018
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Director Share Dealing
Alliance Pharma plc (AIM: APH), the international specialty pharmaceutical group, announces that it was notified on 9 November 2018 that, on the same day, John Dawson, Non-Executive Director, sold 1,100,000 ordinary shares of 1 pence each in the Company at a price of 70.1 pence per share.
Following this transaction, Mr Dawson's total interest in the Company is 55,476,402 ordinary shares, representing approximately 10.71 per cent of the Company's current issued share capital (comprised of a total beneficial interest in 35,476,402 Ordinary Shares, representing 6.85 per cent of the issued share capital, and a total non-beneficial interest in 20,000,000 Ordinary Shares, representing 3.86 per cent of the issued share capital).
For further information:
Alliance Pharma plc | + 44 (0)1249 466966 |
Peter Butterfield, Chief Executive Officer | |
Andrew Franklin, Chief Financial Officer | |
www.alliancepharma.co.uk | |
Buchanan | + 44 (0)20 7466 5000 |
Mark Court / Sophie Wills / Gemma Mostyn-Owen | |
Numis Securities Limited | + 44 (0)20 7260 1000 |
Nominated Adviser: Michael Meade / Freddie Barnfield | |
Corporate Broking: James Black |
Investec Bank plc | + 44 (0) 20 7597 5970 |
Corporate Finance: Daniel Adams / Ed Thomas | |
Corporate Broking: Patrick Robb / David Herring |
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by person discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Mr John Dawson | |
2 | Reason for the notification | ||
a) | Position/status | Non-Executive Director | |
b) | Initial notification /Amendment | Initial Notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Alliance Pharma plc | |
b) | Legal Entity Identifier | 213800RYIWZA4Q5WPZ13 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1.0 pence each
ISIN: GB0031030819 | |
b) | Nature of the transaction | Sale of shares | |
c) | Currency | GBP | |
d) | Price(s) and volume(s) | Price (p) | Volume(s) |
70.1p | 1,100,000 | ||
| |||
e) | Aggregated information - Aggregated volume - Price - Aggregated total |
1,100,000 ordinary shares 70.1p £770,720.01 | |
f) | Date of the transaction | 9 November 2018 | |
g) | Place of the transaction | London Stock Exchange, AIM | |
Alliance Pharma (APH)